Professor Graham’s team has recently pinpointed bowel cancer’s ‘Big Bang’ moment – the point at which cancer cells first evade the immune system through DNA changes that ...

Need to find a specific expert or member of a research group or division? Just search by role, division, name or browse our researchers A-Z.

The Division of Radiotherapy and Imaging is investigating new imaging methods to diagnose cancer, and ways in which advances ...

The overuse of CT scans could cause over 100,000 cases of cancer in the US – with almost 10,000 cases in children, researchers have warned. According to a new modelling study, published in the journal ...

As we enter 2026, scientists at The Institute of Cancer Research, London, share the developments expected this year that could soon change how cancer is treated – from technologies designed to deliver ...

Prostate cancer guidelines should change so that all men from the age of 40 with mutations in either the BRCA1 or BRCA2 gene are offered regular PSA testing to detect early signs of the disease, ...

Experts at The Institute of Cancer Research, London, have responded to the draft recommendation from the National Screening Committee (NSC) to implement a targeted prostate cancer screening programme ...

Radiotheranostics is an exciting new field that has the potential to transform how cancers are detected and treated. Robbie Lockyer finds out more. Radiotheranostics, a groundbreaking approach that ...

Professor Paul Workman was 37 and already well established as a cancer researcher when his mother, Ena, died aged 68 from a rare bone tumour known as chordoma. About one in a million people are ...

A new drug is having a dramatic effect on shrinking lung cancer tumours, according to new research. A trial testing the drug zongertinib as a first treatment for people with advanced lung cancer who ...

Image: A scanning electron microscope image of a prostate cancer cell. Credit: Anne Weston, Francis Crick Institute. CC BY-NC 4.0. At The Institute of Cancer Research, London, we often refer to ...

The Institute of Cancer Research, London, has welcomed the approval of a new combination of two drugs for a rare form of ovarian cancer by the US regulatory body the Food and Drug Administration (FDA) ...